Selected research
Industry Research
Veterinary Antibiotics Industry Research Report 2026
Market perspective
The global Veterinary Antibiotics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Veterinary Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Veterinary Antibiotics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Veterinary Antibiotics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Veterinary Antibiotics include Boehringer Ingelheim, Ceva Animal Health, Inc., Elanco, Merial (Animal Health Division Of Sanofi), Virbac, Bayer healthcare, Merck and Zoetis animal healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Veterinary Antibiotics market in terms of revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary Antibiotics Market by Company
Boehringer Ingelheim
Ceva Animal Health, Inc.
Elanco
Merial (Animal Health Division Of Sanofi)
Virbac
Bayer healthcare
Merck
Zoetis animal healthcare
Veterinary Antibiotics Segment by Type
Tetracyclines
Penicillins
Sulphonamides
Macrolides
Aminoglycosides
Veterinary Antibiotics Segment by Application
Farm Animals
Companion Animals
Veterinary Antibiotics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Antibiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Antibiotics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Antibiotics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tetracyclines
- Penicillins
- Sulphonamides
- Macrolides
- Aminoglycosides
Applications
- Farm Animals
- Companion Animals
Companies covered
- Boehringer Ingelheim
- Ceva Animal Health, Inc.
- Elanco
- Merial (Animal Health Division Of Sanofi)
- Virbac
- Bayer healthcare
- Merck
- Zoetis animal healthcare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Veterinary Antibiotics Market Size (2021-2032)
- 2.2.2 Global Veterinary Antibiotics Sales (2021-2032)
- 2.2.3 Global Veterinary Antibiotics Market Average Price (2021-2032)
- 2.3 Veterinary Antibiotics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tetracyclines
- 2.3.3 Penicillins
- 2.3.4 Sulphonamides
- 2.3.5 Macrolides
- 2.3.6 Aminoglycosides
- 2.4 Veterinary Antibiotics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Farm Animals
- 2.4.3 Companion Animals
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Veterinary Antibiotics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Veterinary Antibiotics Sales (K Tons) of Manufacturers (2021-2026)
- 3.3 Global Veterinary Antibiotics Revenue of Manufacturers (2021-2026)
- 3.4 Global Veterinary Antibiotics Average Price by Manufacturers (2021-2026)
- 3.5 Global Veterinary Antibiotics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Veterinary Antibiotics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Veterinary Antibiotics, Product Type & Application
- 3.8 Global Manufacturers of Veterinary Antibiotics, Established Date
- 3.9 Global Veterinary Antibiotics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Boehringer Ingelheim
- 4.1.1 Boehringer Ingelheim Company Information
- 4.1.2 Boehringer Ingelheim Business Overview
- 4.1.3 Boehringer Ingelheim Veterinary Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Boehringer Ingelheim Veterinary Antibiotics Product Portfolio
- 4.1.5 Boehringer Ingelheim Recent Developments
- 4.2 Ceva Animal Health, Inc.
- 4.2.1 Ceva Animal Health, Inc. Company Information
- 4.2.2 Ceva Animal Health, Inc. Business Overview
- 4.2.3 Ceva Animal Health, Inc. Veterinary Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Ceva Animal Health, Inc. Veterinary Antibiotics Product Portfolio
- 4.2.5 Ceva Animal Health, Inc. Recent Developments
- 4.3 Elanco
- 4.3.1 Elanco Company Information
- 4.3.2 Elanco Business Overview
- 4.3.3 Elanco Veterinary Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Elanco Veterinary Antibiotics Product Portfolio
- 4.3.5 Elanco Recent Developments
- 4.4 Merial (Animal Health Division Of Sanofi)
- 4.4.1 Merial (Animal Health Division Of Sanofi) Company Information
- 4.4.2 Merial (Animal Health Division Of Sanofi) Business Overview
- 4.4.3 Merial (Animal Health Division Of Sanofi) Veterinary Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merial (Animal Health Division Of Sanofi) Veterinary Antibiotics Product Portfolio
- 4.4.5 Merial (Animal Health Division Of Sanofi) Recent Developments
- 4.5 Virbac
- 4.5.1 Virbac Company Information
- 4.5.2 Virbac Business Overview
- 4.5.3 Virbac Veterinary Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Virbac Veterinary Antibiotics Product Portfolio
- 4.5.5 Virbac Recent Developments
- 4.6 Bayer healthcare
- 4.6.1 Bayer healthcare Company Information
- 4.6.2 Bayer healthcare Business Overview
- 4.6.3 Bayer healthcare Veterinary Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bayer healthcare Veterinary Antibiotics Product Portfolio
- 4.6.5 Bayer healthcare Recent Developments
- 4.7 Merck
- 4.7.1 Merck Company Information
- 4.7.2 Merck Business Overview
- 4.7.3 Merck Veterinary Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merck Veterinary Antibiotics Product Portfolio
- 4.7.5 Merck Recent Developments
- 4.8 Zoetis animal healthcare
- 4.8.1 Zoetis animal healthcare Company Information
- 4.8.2 Zoetis animal healthcare Business Overview
- 4.8.3 Zoetis animal healthcare Veterinary Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Zoetis animal healthcare Veterinary Antibiotics Product Portfolio
- 4.8.5 Zoetis animal healthcare Recent Developments
5 Global Veterinary Antibiotics Market Scenario by Region
- 5.1 Global Veterinary Antibiotics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Veterinary Antibiotics Sales by Region: 2021-2032
- 5.2.1 Global Veterinary Antibiotics Sales by Region: 2021-2026
- 5.2.2 Global Veterinary Antibiotics Sales by Region: 2027-2032
- 5.3 Global Veterinary Antibiotics Revenue by Region: 2021-2032
- 5.3.1 Global Veterinary Antibiotics Revenue by Region: 2021-2026
- 5.3.2 Global Veterinary Antibiotics Revenue by Region: 2027-2032
- 5.4 North America Veterinary Antibiotics Market Facts & Figures by Country
- 5.4.1 North America Veterinary Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Veterinary Antibiotics Sales by Country (2021-2032)
- 5.4.3 North America Veterinary Antibiotics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Veterinary Antibiotics Market Facts & Figures by Country
- 5.5.1 Europe Veterinary Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Veterinary Antibiotics Sales by Country (2021-2032)
- 5.5.3 Europe Veterinary Antibiotics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Veterinary Antibiotics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Veterinary Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Veterinary Antibiotics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Veterinary Antibiotics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Veterinary Antibiotics Market Facts & Figures by Country
- 5.7.1 South America Veterinary Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Veterinary Antibiotics Sales by Country (2021-2032)
- 5.7.3 South America Veterinary Antibiotics Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Veterinary Antibiotics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Veterinary Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Veterinary Antibiotics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Veterinary Antibiotics Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Veterinary Antibiotics Sales by Type (2021-2032)
- 6.1.1 Global Veterinary Antibiotics Sales by Type (2021-2032) & (K Tons)
- 6.1.2 Global Veterinary Antibiotics Sales Market Share by Type (2021-2032)
- 6.2 Global Veterinary Antibiotics Revenue by Type (2021-2032)
- 6.2.1 Global Veterinary Antibiotics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Veterinary Antibiotics Revenue Market Share by Type (2021-2032)
- 6.3 Global Veterinary Antibiotics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Veterinary Antibiotics Sales by Application (2021-2032)
- 7.1.1 Global Veterinary Antibiotics Sales by Application (2021-2032) & (K Tons)
- 7.1.2 Global Veterinary Antibiotics Sales Market Share by Application (2021-2032)
- 7.2 Global Veterinary Antibiotics Revenue by Application (2021-2032)
- 7.2.1 Global Veterinary Antibiotics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Veterinary Antibiotics Revenue Market Share by Application (2021-2032)
- 7.3 Global Veterinary Antibiotics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Veterinary Antibiotics Value Chain Analysis
- 8.1.1 Veterinary Antibiotics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Veterinary Antibiotics Production Mode & Process
- 8.2 Veterinary Antibiotics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Veterinary Antibiotics Distributors
- 8.2.3 Veterinary Antibiotics Customers
9 Global Veterinary Antibiotics Analyzing Market Dynamics
- 9.1 Veterinary Antibiotics Industry Trends
- 9.2 Veterinary Antibiotics Industry Drivers
- 9.3 Veterinary Antibiotics Industry Opportunities and Challenges
- 9.4 Veterinary Antibiotics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst